Download full-text PDF |
Source |
---|
Health Promot Chronic Dis Prev Can
March 2025
Evidence Synthesis and Knowledge Translation Unit, Centre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Introduction: We investigated the prevalence of new or persistent manifestations experienced by COVID-19 survivors at 3 or more months after their initial infection, collectively known as post-COVID-19 condition (PCC).
Methods: We searched four electronic databases and major grey literature resources for prospective studies, systematic reviews, authoritative reports and population surveys. A random-effects meta-analysis pooled the prevalence data of 22 symptoms and outcomes.
Health Promot Chronic Dis Prev Can
March 2025
Public Health Agency of Canada, Ottawa, Ontario, Canada.
Health Promotion and Chronic Disease Prevention in Canada (the HPCDP Journal) is uniquely positioned to serve diverse audiences by presenting valuable contributions to the field of public health from scientists within and outside of government. The HPCDP Journal marking its 10th anniversary under the current name is an opportune time to reflect on how far the journal, the editorial team and the community of contributors have come.
View Article and Find Full Text PDFDilated cardiomyopathy is a rare and often little-known complication of pheochromocytoma, it is likewise exceptionally its discovery circumstance. This is usually an acute, reversible cardiomyopathy.We report the case of a 20-year-old young adult hospitalized for hypokinetic dilated cardiomyopathy with severe impairment of left ventricular ejection fraction (LVEF) to 17%.
View Article and Find Full Text PDFERJ Open Res
March 2025
Service de Pneumologie A, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
https://bit.ly/3TMWKK9.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!